Landry Robert E's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Mar 29, 2023
- Accession no.
- 0001968202-23-000004
- Filed
- Mar 29, 2023
- Trade date
- Mar 27-28, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 20 non-derivative transactions and 2 derivative transactions. Open-market sales total $979.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Landry Robert ECIK 0001585160 | Officer (EVP Finance CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | Common Stock | MOption exerciseAcquired | +800 | $381.92 | +$305,536 | 32,905 | Direct | |
| Mar 27, 2023 | Common Stock | FTax withholdingDisposed | −589 | $825.17 | −$486,025.13 | 32,316 | Direct | |
| Mar 27, 2023 | Common Stock | MOption exerciseAcquired | +3,000 | $378.98 | +$1,136,940 | 35,316 | Direct | |
| Mar 27, 2023 | Common Stock | FTax withholdingDisposed | −2,204 | $825.17 | −$1,818,674.68 | 33,112 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −39 | $819.47 | −$31,959.33 | 33,073 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −50 | $820.46 | −$41,023 | 33,023 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −48 | $821.39 | −$39,426.72 | 32,975 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −18 | $822.57 | −$14,806.26 | 32,957 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −4 | $824.30 | −$3,297.2 | 32,953 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −13 | $825.59 | −$10,732.67 | 32,940 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −4 | $829.16 | −$3,316.64 | 32,936 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −7 | $830.01 | −$5,810.07 | 32,929 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −10 | $818.81 | −$8,188.1 | 32,919 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −115 | $820.85 | −$94,397.75 | 32,804 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −142 | $821.40 | −$116,638.8 | 32,662 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −128 | $822.67 | −$105,301.76 | 32,534 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −181 | $823.60 | −$149,071.6 | 32,353 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −157 | $824.54 | −$129,452.78 | 32,196 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −243 | $825.37 | −$200,564.91 | 31,953 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −31 | $826.36 | −$25,617.16 | 31,922 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | Common Stock | MOption exerciseDisposed | −3,000 | $0.00 | $0 | 20,337 | Direct | |
| Mar 27, 2023 | Common Stock | MOption exerciseDisposed | −800 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.